Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood

Cellular Immunology

Volumn 304-305, Issue , 2016, Pages 35-43

  Bancroft, Tara ^a   Dillon, Myles B C ^a   da Silva Antunes, Ricardo ^a   Paul, Sinu ^a   Peters, Bjoern ^a   Crotty, Shane ^a   Lindestam Arlehamn, Cecilia S ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Epitope; Pertussis; Re immunization; T cell polarization; Vaccine

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 5; PERTUSSIS VACCINE; ACELLULAR VACCINE; BACTERIAL ANTIGEN; BACTERIAL VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOREACTIVITY; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERTUSSIS; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; AGE; ANTIBODY PRODUCTION; BORDETELLA PERTUSSIS; CELL CULTURE; CHILD; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PRESCHOOL CHILD; PROCEDURES; SECONDARY IMMUNIZATION; TH1 TH2 BALANCE; WHOOPING COUGH; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BORDETELLA PERTUSSIS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; INTERLEUKIN-5; TH1 CELLS; TH1-TH2 BALANCE; TH2 CELLS; VACCINES, ACELLULAR; WHOOPING COUGH; YOUNG ADULT;

EID: 84971472913     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2016.05.002     Document Type: Article

References (38)

1. Pertussis Cases by Year. Center for Disease Control, Marc 6 (2015).
2. Pertussis Outbreak Trends. Center for Disease Control (2015).
3. Cody C.L., Baraff L.J., Cherry J.D., Marcy S.M., Manclark C.R. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics 1981, 68:650-660.
4. Sato Y., Sato H. Development of acellular pertussis vaccines. Biologicals 1999, 27:61-69.
5. C.Report FDA approved of use of diphtheria and tetanus toxoid and acellular pertussis vaccine 1992, JAMA, pp. 485.
6. C.f.D. Control, Pertussis Vaccination: Acellular pertussis vaccine for the fourth and fifth doses of the DTP series; update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP), in, MMWR, 1992, pp. 1-5.
7. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., Wharton M., Livengood J.R. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin. Infect. Dis. 1999, 28:1230-1237.
8. Plotkin S.A. The pertussis problem. Clin. Infect. Dis. 2014, 58:830-833.
9. Chiappini E., Stival A., Galli L., de Martino M. Pertussis re-emergence in the post-vaccination era. BMC Infect. Dis. 2013, 13:151.
10. Edwards K.M., Berbers G.A. Immune responses to pertussis vaccines and disease. J. Infect. Dis. 2014, 209(Suppl 1):S10-S15.
11. Watanabe M., Connelly B., Weiss A.A. Characterization of serological responses to pertussis. Clin. Vaccine Immunol. 2006, 13:341-348.
12. Halperin B.A., Morris A., Mackinnon-Cameron D., Mutch J., Langley J.M., McNeil S.A., Macdougall D., Halperin S.A. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin. Infect. Dis. 2011, 53:885-892.
13. Teunis P.F., van der Heijden O.G., de Melker H.E., Schellekens J.F., Versteegh F.G., Kretzschmar M.E. Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol. Infect. 2002, 129:479-489.
14. Aase A., Herstad T.K., Jorgensen S.B., Leegaard T.M., Berbers G., Steinbakk M., Aaberge I. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age. Vaccine 2014, 32:5931-5936.
15. McIntyre P.B., Turnbull F.M., Egan A.M., Burgess M.A., Wolter J.M., Schuerman L.M. High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine. Vaccine 2004, 23:380-385.
16. Le T., Cherry J.D., Chang S.J., Knoll M.D., Lee M.L., Barenkamp S., Bernstein D., Edelman R., Edwards K.M., Greenberg D., Keitel W., Treanor J., Ward J.I., Study A. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J. Infect. Dis. 2004, 190:535-544.
17. Barnard A., Mahon B.P., Watkins J., Redhead K., Mills K.H. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 1996, 87:372-380.
18. Rowe J., Macaubas C., Monger T.M., Holt B.J., Harvey J., Poolman J.T., Sly P.D., Holt P.G. Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized. Infect. Immun. 2000, 68:3873-3877.
19. Rowe J., Yerkovich S.T., Richmond P., Suriyaarachchi D., Fisher E., Feddema L., Loh R., Sly P.D., Holt P.G. Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children. Infect. Immun. 2005, 73:8130-8135.
20. Sallusto F., Lenig D., Mackay C.R., Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 1998, 187:875-883.
21. Rivino L., Messi M., Jarrossay D., Lanzavecchia A., Sallusto F., Geginat J. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J. Exp. Med. 2004, 200:725-735.
22. van Twillert I., Han W.G., van Els C.A. Waning and aging of cellular immunity to Bordetella pertussis. Pathog. Dis. 2015, 73:ftv071.
23. Oseroff C., Sidney J., Vita R., Tripple V., McKinney D.M., Southwood S., Brodie T.M., Sallusto F., Grey H., Alam R., Broide D., Greenbaum J.A., Kolla R., Peters B., Sette A. T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extracts. J. Immunol. 2012, 189:1800-1811.
24. Schulten V., Greenbaum J.A., Hauser M., McKinney D.M., Sidney J., Kolla R., Lindestam Arlehamn C.S., Oseroff C., Alam R., Broide D.H., Ferreira F., Grey H.M., Sette A., Peters B. Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:3459-3464.
25. McKinney D.M., Fu Z., Le L., Greenbaum J.A., Peters B., Sette A. Development and validation of a sample sparing strategy for HLA typing utilizing next generation sequencing. Hum. Immunol. 2015.
26. Paul S., Dillon M.B., Lindestam Arlehamn C.S., Huang H., Davis M.M., McKinney D.M., Scriba T.J., Sidney J., Peters B., Sette A. A population response analysis approach to assign class II HLA-epitope restrictions. J. Immunol. 2015, 194:6164-6176.
27. Lindestam Arlehamn C.S., Gerasimova A., Mele F., Henderson R., Swann J., Greenbaum J.A., Kim Y., Sidney J., James E.A., Taplitz R., McKinney D.M., Kwok W.W., Grey H., Sallusto F., Peters B., Sette A. Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset. PLoS Pathog. 2013, 9:e1003130.
28. Ryan E.J., Nilsson L., Kjellman N., Gothefors L., Mills K.H. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin. Exp. Immunol. 2000, 121:193-200.
29. Bisgard K.M., Rhodes P., Connelly B.L., Bi D., Hahn C., Patrick S., Glode M.P., Ehresmann K.R. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics 2005, 116:e285-e294.
30. Ausiello C.M., Urbani F., la Sala A., Lande R., Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 1997, 65:2168-2174.
31. Zepp F., Knuf M., Habermehl P., Schmitt J.H., Rebsch C., Schmidtke P., Clemens R., Slaoui M. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect. Immun. 1996, 64:4078-4084.
32. Ryan M., Murphy G., Ryan E., Nilsson L., Shackley F., Gothefors L., Oymar K., Miller E., Storsaeter J., Mills K.H. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 1998, 93:1-10.
33. Smits K., Pottier G., Smet J., Dirix V., Vermeulen F., De Schutter I., Carollo M., Locht C., Ausiello C.M., Mascart F. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. Vaccine 2013, 32:111-118.
34. Han W.G., van Twillert I., Poelen M.C., Helm K., van de Kassteele J., Verheij T.J., Versteegh F.G., Boog C.J., van Els C.A. Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age. PLoS ONE 2013, 8:e83583.
35. Vaughan K., Seymour E., Peters B., Sette A. Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy. Hum. Immunol. 2014, 75:440-451.
36. Vita R., Overton J.A., Greenbaum J.A., Ponomarenko J., Clark J.D., Cantrell J.R., Wheeler D.K., Gabbard J.L., Hix D., Sette A., Peters B. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 2015, 43:D405-D412.
37. Han W.G., Helm K., Poelen M.M., Otten H.G., van Els C.A. Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4(+) T cells following clinical infection. Clin. Immunol. 2015, 157:205-215.
38. Stenger R.M., Meiring H.D., Kuipers B., Poelen M., van Gaans-van J.A., den Brink C.J., de Boog A.P., van Jong Els C.A. Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells. Clin. Vaccine Immunol. 2014, 21:641-650.